UBXN7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.07419999953551E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.394100E-04 |
Normal-vs-Stage2 |
5.94210000000039E-05 |
Normal-vs-Stage3 |
1.42229999999799E-08 |
Normal-vs-Stage4 |
4.84040000303665E-08 |
Stage1-vs-Stage2 |
1.068200E-01 |
Stage1-vs-Stage3 |
6.586400E-04 |
Stage1-vs-Stage4 |
1.321670E-03 |
Stage2-vs-Stage3 |
3.554400E-01 |
Stage2-vs-Stage4 |
2.814800E-01 |
Stage3-vs-Stage4 |
7.864800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.22759999948907E-07 |
Normal-vs-AfricanAmerican |
4.09829999999944E-05 |
Normal-vs-Asian |
8.995800E-01 |
Caucasian-vs-AfricanAmerican |
3.945200E-01 |
Caucasian-vs-Asian |
1.438780E-01 |
AfricanAmerican-vs-Asian |
1.036400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.2170000002486E-07 |
Normal-vs-Female |
4.23120000000443E-05 |
Male-vs-Female |
5.118400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.318000E-02 |
Normal-vs-Age(41-60Yrs) |
2.775200E-04 |
Normal-vs-Age(61-80Yrs) |
7.88220000380591E-09 |
Normal-vs-Age(81-100Yrs) |
2.30169999999585E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.798200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.662600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.809020E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.001560E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.537700E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.376200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.487200E-01 |
Normal-vs-Grade 2 |
3.382000E-04 |
Normal-vs-Grade 3 |
2.16120000007258E-07 |
Normal-vs-Grade 4 |
7.48880002454655E-09 |
Grade 1-vs-Grade 2 |
5.577900E-02 |
Grade 1-vs-Grade 3 |
4.098500E-03 |
Grade 1-vs-Grade 4 |
7.389000E-04 |
Grade 2-vs-Grade 3 |
2.173500E-02 |
Grade 2-vs-Grade 4 |
8.970000E-04 |
Grade 3-vs-Grade 4 |
7.167800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.580800E-03 |
Normal-vs-ccB subtype |
1.72164999999724E-05 |
ccA subtype-vs-ccB subtype |
2.479700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.7018099999988E-05 |
Normal-vs-N1 |
8.119600E-02 |
N0-vs-N1 |
8.340000E-01 |
|
|